These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19231068)
21. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion. Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793 [TBL] [Abstract][Full Text] [Related]
22. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516 [TBL] [Abstract][Full Text] [Related]
23. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437 [TBL] [Abstract][Full Text] [Related]
24. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323 [TBL] [Abstract][Full Text] [Related]
25. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro. Gruber HE; Marrero E; Ingram JA; Hoelscher GL; Hanley EN Biotech Histochem; 2017; 92(1):7-14. PubMed ID: 27869573 [TBL] [Abstract][Full Text] [Related]
26. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation. Cullen R; Germanov E; Shimaoka T; Johnston B J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206 [TBL] [Abstract][Full Text] [Related]
27. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling. Li Y; Fu LX; Zhu WL; Shi H; Chen LJ; Ye B Int J Immunopathol Pharmacol; 2015 Jun; 28(2):194-200. PubMed ID: 25921630 [TBL] [Abstract][Full Text] [Related]
28. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Wu X; Fan J; Wang X; Zhou J; Qiu S; Yu Y; Liu Y; Tang Z Biochem Biophys Res Commun; 2007 Apr; 355(4):866-71. PubMed ID: 17336272 [TBL] [Abstract][Full Text] [Related]
30. [Enhancement effects of hypoxia on invasion and metastasis of K562 cells]. Nie YM; Dai BT Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):566-70. PubMed ID: 19650992 [TBL] [Abstract][Full Text] [Related]
31. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer]. Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641 [TBL] [Abstract][Full Text] [Related]
32. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering. Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186 [TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. Michaud MD; Robitaille GA; Gratton JP; Richard DE Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865 [TBL] [Abstract][Full Text] [Related]
34. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. del Rey MJ; Izquierdo E; Caja S; Usategui A; Santiago B; Galindo M; Pablos JL Arthritis Rheum; 2009 Oct; 60(10):2926-34. PubMed ID: 19790065 [TBL] [Abstract][Full Text] [Related]
35. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma. Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951 [TBL] [Abstract][Full Text] [Related]
36. CXCL16 and CXCR6 in Ewing sarcoma family tumor. Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753 [TBL] [Abstract][Full Text] [Related]
37. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells. Lee HS; Hong JE; Kim EJ; Kim SH Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042 [TBL] [Abstract][Full Text] [Related]
38. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions. Chen C; Yu Z Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389 [TBL] [Abstract][Full Text] [Related]
39. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560 [TBL] [Abstract][Full Text] [Related]
40. The involvement of hypoxia-inducible factor 1 alpha in Toll-like receptor 7/8-mediated inflammatory response. Nicholas SA; Sumbayev VV Cell Res; 2009 Aug; 19(8):973-83. PubMed ID: 19381167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]